What is the current BAYN.DE stock price and trading venue?

BAYN.DE stock is trading pre-market on XETRA (Germany) at **€38.95** on 14 Jan 2026, with a day range of **€38.70–€39.65** and volume near **2,810,650** shares.

When does Bayer report earnings and what matters next?

Bayer’s next earnings announcement is scheduled for **25 Feb 2026**. Investors will watch revenue trends, guidance, and updates on Nubeqa, Kerendia, Eylea pricing, and Xarelto erosion for forward guidance.

How does Meyka AI evaluate BAYN.DE stock?

Meyka AI rates BAYN.DE **64.15/100 (Grade B, HOLD)**. The grade considers benchmark and sector comparisons, financial growth, key metrics, forecasts, and analyst data. Grades are informational and not financial advice.

What are realistic price targets for BAYN.DE stock?

Scenario targets: conservative **€31.00**, base **€39.00**, and bull **€50.00**. These reflect current valuation, pipeline upside, and risks from LOE and leverage; adjust sizing based on risk tolerance.

DE Stocks

BAYN.DE €38.95 pre-market XETRA 14 Jan 2026: Catalysts may drive moves

ByDanny Kontos January 14, 2026January 14, 2026

The BAYN.DE stock opened pre-market on XETRA at €38.95, down -1.91% from the previous close as traders digest recent JPM Healthcare commentary and updated product readouts. Trading volume sits near 2,810,650 shares versus an average of 2,870,582, keeping Bayer in the most active list for Germany this morning. Investors are watching near-term pharma catalysts — including readouts and new launches — that could push the share price above the 50-day average of €33.14 or expose downside into the low €30s.